Kathleen D. Scott

CIK 1794284 · Chief Financial Officer · last filed 2026-01-06

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$178.8K

Companies

4

Total Filings

21

Lifetime Open-Market Net

-$1.24M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
DRMAW Director 29,584 $0.01 $302 $0 8 2026-01-06
SPRY Chief Financial Officer 18,292 $9.76 $178.5K -$1.24M 10 2026-01-05
NKGen Biotech, Inc. (NKGNW) Delisted Director $0.03 $0 2 2024-12-10
Histogen Inc. (CNAT) Delisted Director $0 1 2019-11-19

Recent Filings · Page 2 of 3

21 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-01-05 DRMAW Grant (A) $0 EDGAR
2024-01-04 SPRY Grant (A) $0 EDGAR
2023-01-05 SPRY Grant (A) $0 EDGAR
2022-12-01 SPRY Buy (P) +8,250 $51.5K EDGAR
2022-11-10 SPRY Grant (A) $0 EDGAR
2022-10-07 DRMAW Grant (A) +11,359 $0 EDGAR
2022-07-08 DRMAW Grant (A) +9,960 $0 EDGAR
2022-04-08 DRMAW Grant (A) +5,826 $0 EDGAR
2022-01-05 DRMAW Grant (A) $0 EDGAR
2021-08-17 DRMAW Grant (A) $0 EDGAR
Showing 1120 of 21
Page 2 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.